|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
Q96H96 |
| Protein name |
4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase) |
| Protein function |
Mediates the second step in the final reaction sequence of coenzyme Q (CoQ) biosynthesis (PubMed:15153069, PubMed:16400613, PubMed:17374725, PubMed:20526342). Catalyzes the prenylation of para-hydroxybenzoate (PHB) with an all-trans polyprenyl d |
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF01040 |
UbiA |
89 → 347 |
UbiA prenyltransferase family |
Family |
|
| Tissue specificity |
TISSUE SPECIFICITY: Widely expressed. Present in all of the tissues tested. Expressed at higher level in skeletal muscle, adrenal glands and the heart. {ECO:0000269|PubMed:15153069}. |
| Sequence |
|
| Sequence length |
371 |
| Interactions |
View interactions |
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Coenzyme Q10 deficiency |
Likely pathogenic; Pathogenic |
rs121918230, rs121918231, rs121918233, rs750710187, rs1057519348 |
RCV000416386 RCV000416395 RCV000416406 RCV000416389 RCV000416391 |
| Coenzyme Q10 deficiency, primary, 1 |
Likely pathogenic; Pathogenic |
rs1734860676, rs767624218, rs1397649685, rs121918230, rs121918231, rs121918233, rs2126177139, rs1169311005, rs750710187, rs1057519348, rs1577993720 |
RCV005034516 RCV001780862 RCV001824233 RCV000001501 RCV000001503 RCV000001505 RCV002505910 RCV003143767 RCV000001502 RCV005033950 RCV000995527 |
| Multiple system atrophy |
Pathogenic |
rs1735008495 |
RCV001333884 |
| Multiple system atrophy 1, susceptibility to |
Likely pathogenic; Pathogenic |
rs1734860676, rs121918231, rs121918233, rs2126177139, rs2529761222, rs750710187, rs1057519348 |
RCV005034516 RCV002504734 RCV002496230 RCV002505910 RCV003333396 RCV005033951 RCV005033950 |
| Neonatal encephalopathy |
Likely pathogenic; Pathogenic |
rs867410805 |
RCV003154307 |
| Nephrotic syndrome |
Likely pathogenic |
rs1198292264 |
RCV001849671 |
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| COQ2-related disorder |
Conflicting classifications of pathogenicity; Uncertain significance; Likely benign |
rs555411841, rs767013819, rs766552045, rs1220218092, rs571021239, rs538352658, rs769268024, rs376948148, rs549493176, rs747575952, rs778586293, rs566165293, rs1379033743, rs1477654289, rs571717352, rs2529782226, rs1227658361, rs561450756, rs551102947, rs6834269, rs550949678, rs1418018696 View all (7 more) |
RCV004754738 RCV003416410 RCV003426227 RCV004754829 RCV003913629 RCV003958694 RCV003408221 RCV003953881 RCV003971316 RCV003898466 RCV003898579 RCV003891770 RCV004731312 RCV003408624 RCV003921758 RCV003894373 RCV003964541 RCV003944160 RCV003951709 RCV003902555 RCV003928163 RCV003413799 |
| Focal segmental glomerulosclerosis |
Benign; Likely benign; Conflicting classifications of pathogenicity |
rs112033303, rs368507578, rs375934957, rs767298430 |
RCV002294039 RCV002294040 RCV002294077 RCV002294084 |
| Kidney disorder |
Uncertain significance |
rs1735006080, rs779191310 |
RCV002294609 RCV002294678 |
| Mitochondrial disease |
Uncertain significance |
rs767013819, rs371993270 |
RCV005369934 RCV005361771 |
| Ovarian serous cystadenocarcinoma |
Uncertain significance |
rs757009353 |
RCV005924242 |
| Uterine corpus endometrial carcinoma |
Conflicting classifications of pathogenicity |
rs776701765 |
RCV005924149 |
|
| Disease Name |
Relationship Type |
References |
| Acute Kidney Injury |
Associate |
31660881 |
| Brain Diseases |
Associate |
33397173 |
| Cerebellar Diseases |
Associate |
19096106, 26096180 |
| Coenzyme Q10 Deficiency |
Associate |
16400613, 17332895, 19096106, 23631824, 25373618, 25564041, 29637272, 31660881, 33187544, 33397173, 35643375 |
| Coenzyme Q10 Deficiency |
Inhibit |
17374725 |
| Cone Rod Dystrophies |
Associate |
33187544 |
| COVID 19 |
Associate |
34232998 |
| Cryopyrin Associated Periodic Syndromes |
Associate |
25373618 |
| Disease |
Associate |
29637272 |
| Dystonia |
Associate |
21868014 |
| Dystonic Disorders |
Associate |
23758206 |
| Genetic Diseases Inborn |
Associate |
17376224 |
| Glomerulosclerosis Focal Segmental |
Associate |
33397173 |
| Hearing Loss Sensorineural |
Associate |
23349334 |
| Hypertensive Retinopathy |
Associate |
33187544, 36420660 |
| Kidney Diseases |
Associate |
17186472, 23349334, 31660881, 33187544, 33397173 |
| Kidney Failure Chronic |
Associate |
31660881, 33187544 |
| Lissencephaly |
Associate |
36168972 |
| Mitochondrial Diseases |
Associate |
17332895 |
| Mitochondrial Encephalomyopathies |
Associate |
17186472 |
| Multiple System Atrophy |
Associate |
23758206, 25373618, 26096180, 26812605, 27374978, 28150130, 30242188 |
| Muscular Diseases |
Associate |
17376224, 30595243 |
| Myalgia |
Associate |
21868014 |
| Nephrotic Syndrome |
Associate |
17186472, 23349334, 29637272, 31660881, 33397173 |
| Nerve Degeneration |
Associate |
30242188 |
| Optic Atrophy |
Associate |
36420660 |
| Renal Insufficiency Chronic |
Associate |
31660881 |
| Senior Loken Syndrome |
Associate |
33187544 |
|